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Abstract: Purpose:  Four patients with Saul-Wilson syndrome were reported between 1982 and
1994, but no additional individuals were described until 2018, when the molecular
etiology of the disease was elucidated. Hence, the clinical phenotype of the disease
remains poorly defined. We address this shortcoming by providing a detailed
characterization of its phenotype. 
Methods:  Retrospective chart reviews were performed and primary radiographs
assessed for all 14 individuals. Four individuals underwent detailed ophthalmologic
examination by the same physician. Two individuals underwent gynecologic
evaluation. Z-scores for height, weight, head circumference and BMI were calculated at
different ages. 
Results:  All patients exhibited short stature, with sharp decline from the mean within
the first months of life, and a final height Z-score between -4 and -8.5 standard
deviations. The facial and radiographic features evolved over time. Intermittent
neutropenia was frequently observed. Novel findings included elevation of liver
transaminases, skeletal fragility, rod-cone dystrophy, and cystic macular changes.
Conclusion:  Saul-Wilson syndrome presents a remarkably uniform phenotype, and the
comprehensive description of our cohort allows for improved understanding of the
long-term morbidity of the condition, establishment of follow-up recommendations for
affected individuals, and documentation of the natural history into adulthood for
comparison with treated patients, when therapeutics become available.
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November 21, 2019 
 
 
Robert D. Steiner, MD 
Editor-in-Chief 
Genetics in Medicine 
 
 
Dear Dr. Steiner,  
 
Please consider the enclosed manuscript, “Defining the clinical phenotype of Saul-
Wilson syndrome”, for publication in Genetics in Medicine.  
 
Saul-Wilson syndrome is a rare skeletal dysplasia, first reported in 1982. Between then 
and 2018, only four patients were reported. Recently, we identified the molecular 
etiology of the disease. However, a detailed clinical characterization of the disease is still 
lacking. Here, we address this shortcoming by performing comprehensive phenotyping of 
14 patients with Saul-Wilson syndrome, including long-term follow-up of two of the 
patients originally reported in the 1990s. We also describe novel findings, including rod-
cone dystrophy, macular cystic changes, elevation of hepatic transaminases, bone 
fragility, and the intermittent pattern of neutropenia in Saul-Wilson syndrome. This 
disease is likely underdiagnosed; since the publication of our molecular paper one year 
ago, we have learned of several new cases diagnosed around the world. Since the current 
submission will represent the only publication with careful delineation of the clinical 
findings and recommendations for management, it will likely serve to call attention to 
this poorly known though likely underrecognized disorder. 
 
We suggest Dr. V. Reid Sutton as the editor for our paper, given his expertise in the field 
of skeletal dysplasias. Recommended reviewers include Dr. Robert A. Saul at Greenville 
Health System (RSaul@ghs.org), Dr. Roberta A. Pagon at University of Washington 
(bpagon@uw.edu), and Dr. Joseph H. Hersh at University of Louisville 
(jhhers01@louisville.edu). Dr. Saul described the original proband with Saul-Wilson 
syndrome back in 1982, and a subsequent follow-up of his patient in 1990 (PMID  
2309787). Dr. Pagon diagnosed a patient in the 1990s (subject P7.1 in our cohort), and 





subject P2.1 in our cohort) that he followed on an annual basis for many years. Thus, the 
three recommended reviewers are some of the few doctors in the world with experience 
in the long-term follow-up of Saul-Wilson syndrome. 
 
This work has not been previously published elsewhere and is entirely novel. It is not 
under consideration at any other journal. Please feel free to contact me if you require any 
additional information.   
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December 16, 2019 
 
 
Robert D. Steiner, MD 
Editor-in-Chief 




Dear Dr. Steiner,  
 
Thank you for editing our manuscript, and for finding it acceptable for publication 
pending final files. We now uploaded all figures in TIFF or PDF format, and moved the 
supplemental legends to a separate online-only supplemental file. The color artwork 
form, license to publish, and reporting checklist were previously uploaded. 
 







Carlos Ferreira, MD, FACMG 
Response to editor's comments
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Purpose: Four patients with Saul-Wilson syndrome were reported between 1982 and 
1994, but no additional individuals were described until 2018, when the molecular 
etiology of the disease was elucidated. Hence, the clinical phenotype of the disease 
remains poorly defined. We address this shortcoming by providing a detailed 
characterization of its phenotype.  
Methods: Retrospective chart reviews were performed and primary radiographs 
assessed for all 14 individuals. Four individuals underwent detailed ophthalmologic 
examination by the same physician. Two individuals underwent gynecologic evaluation. 
Z-scores for height, weight, head circumference and BMI were calculated at different 
ages.  
Results: All patients exhibited short stature, with sharp decline from the mean within 
the first months of life, and a final height Z-score between -4 and -8.5 standard 
deviations. The facial and radiographic features evolved over time. Intermittent 
neutropenia was frequently observed. Novel findings included elevation of liver 
transaminases, skeletal fragility, rod-cone dystrophy, and cystic macular changes. 
Conclusion: Saul-Wilson syndrome presents a remarkably uniform phenotype, and the 
comprehensive description of our cohort allows for improved understanding of the long-
term morbidity of the condition, establishment of follow-up recommendations for 
affected individuals, and documentation of the natural history into adulthood for 
comparison with treated patients, when therapeutics become available. 
 




Saul-Wilson syndrome is a rare skeletal dysplasia originally described in 1982 in a child 
with bulging fontanelles, left clubfoot, severe short stature, blue sclerae, bilateral 
cataracts, blunted fingertips, and frequent otitis media with hearing loss.1 In 1990, an 
update was provided on the original proband, and a second patient with similar features 
was reported,2,3 while two additional affected individuals were described in 1994.4 
Recently, a recurrent de novo heterozygous COG4 amino acid substitution 
(p.Gly516Arg) was identified in 14 patients with the disease, including two of the four 
original individuals described in the 1990s.5 COG4 is a component of the Conserved 
Oligomeric Golgi (COG) complex, a hetero-octameric protein complex that regulates 
vesicular trafficking between the Golgi apparatus and the endoplasmic reticulum (ER). 
Patients’ fibroblasts demonstrated accelerated retrograde Golgi-to-ER vesicular 
trafficking, while at the same time showing delayed anterograde ER-to-Golgi trafficking, 
leading to disruption of the Golgi apparatus, with decreased volume and stack collapse. 
The glycosylation of a secreted proteoglycan, which normally takes place in the Golgi 
apparatus, was found to be impaired.5  
 
Although the aforementioned work provides insight into the pathophysiology of the 
disease, a comprehensive clinical characterization of the phenotype is still needed. Our 
present work attempts to address this knowledge gap, as we provide an extensive 







P1.1 was enrolled in protocol 15-HG-0130, “Clinical and Genetic Evaluation of 
Individuals with Undiagnosed Disorders Through the Undiagnosed Diseases Network” 
(NCT02450851).6–8 P1.1, P2.1, P7.1 and P10.1 were enrolled in 14-HG-0071 “Clinical 
and Basic Investigations into Known and Suspected Congenital Disorders of 
Glycosylation” (NCT02089789). P3.1, P4.1, P5.1, P6.1, P9.1, P10.1, P11.1, P12.1 and 
P13.1 were enrolled in protocol 76-HG-0238, “Diagnosis and Treatment of Patients with 
Inborn Errors of Metabolism or other Genetic Disorders” (NCT00369421). The 
aforementioned protocols were approved by the National Human Genome Research 
Institute (NHGRI) Institutional Review Board (IRB). P3.1, P4.1 and P8.1 were enrolled in 
protocol “Enquiry of Participation in a Research Project about Clinical and Molecular 
Studies on Rare Congenital Skeletal Disorders”, approved by the IRB of the Karolinska 
Institute in Sweden (2014/983-31/1). P2.1, P5.1, P5.2 and P7.1 were enrolled in the 
Primordial Registry at Nemours/Alfred I. duPont Hospital for Children, approved by the 
Nemours IRB. Written informed consent was obtained from all affected individuals or 
their parents/legal guardians; consent was also obtained for publication of patient 
photos, where appropriate. All 14 individuals were presented in a prior publication, 
focused on the molecular characterization of the disease.5 
 
Data collection 
Clinical and laboratory data were abstracted from the medical records by retrospective 
chart review. Further data were collected by direct interaction with participating 
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individuals or their parents. Radiographic images were reviewed for all patients. 
 
Ophthalmologic evaluation 
Comprehensive age-appropriate eye evaluations were performed on four patients who 
visited the NIH Clinical Center. These included an evaluation of visual acuity, color 
vision, stereopsis, ocular motility assessment, mapping of visual fields with MonCV 
kinetic perimetry (Metrovision, Pérenchies, France), measurement of axial length 
(IOLMaster, Carl Zeiss Meditec, Dublin, CA), slit-lamp microscopy, dilated fundus exam, 
and retinoscopy to assess refractive error. Part of this assessment was performed at a 
sedated eye exam for P1.1. Ancillary testing, when visit time and patient cooperation 
level allowed, included electroretinography with a UTAS console (LKC Technologies, 
Gaithersburg, MD) and Burian-Allen bipolar contact lens electrodes (Hansen Labs, 
Coralville, IA), color fundus photography (CFP) and fundus autofluorescence (FAF) 
imaging with Topcon (Topcon Medical Systems, Oakland, NJ), RetCAM3 (Clarity 
Medical System Inc., Pleasanton, CA), or Optos (Optos, Dumfermline, Scotland, UK) 
imaging systems, and Optical Coherence Tomography utilizing a Cirrus HD-OCT 
machine (Carl Zeiss Meditec, Dublin, CA). 
 
Gynecologic evaluation 
P2.1 and P7.1 underwent gynecologic evaluation through review of history and 





Growth data was available for 13 affected individuals. Growth parameters were 
corrected for gestational age. Individual growth parameters (height, weight, head 
circumference, and body mass index) were calculated at age groups selected a priori, 
as follows: birth, 3 months, 6 months, 9 months, 12 months, 18 months, 2 years, 3 
years, 4 years, 5 years, 6 years, 7 years and 8 years. Subsequently, mean, median, 
standard deviations, and Z-scores were calculated according to WHO9,10 and UK9011–13 
references. For a graphic comparison of length/height to achondroplasia, stature 
reference from a European cohort was used.14 
 
RESULTS 
Clinical summaries for all patients are provided in the Supplementary Materials, 
Appendix 1.  
 
Dysmorphic features 
The characteristic facial features are depicted in figure 1 and supplementary figure S1. 
During early infancy, patients have progeroid features that disappear within the first few 
months of life. Blue sclerae are also seen in early infancy, and can persist for several 
months. The scalp veins become particularly prominent in late infancy and during the 
toddler years. The columella becomes prominent during the first few years of life. In late 
childhood, the shape of the forehead, which was round in early childhood, becomes 
taller and less round. Short distal phalanges of the fingers and toes of variable severity 





The ocular manifestations of the four patients (P1.1, P2.1, P7.1 and P10.1) with 
comprehensive eye exams performed at the NIH Ophthalmic Genetics clinic are 
summarized in supplementary table S1 and documented in figure 2. All four had 
lamellar cataracts or a history of cataract extraction (with childhood-onset cataract). In 
addition, several whose ophthalmic histories were reviewed had progression of lamellar 
cataracts requiring surgical intervention in early adulthood. Nystagmus was present in 
two of the four individuals who visited the NIH Clinical Center. The underlying cause is 
difficult to ascertain but is likely multifactorial with a central element. Two of the four 
individuals examined at the NIH Ophthalmic Genetics clinic had small eyes with short 
axial length. Hyperopic refractive error was noted for these two patients as expected for 
short axial length; the other two had axial length within the normal range and were 
mildly myopic. A pigmentary retinopathy consistent with a rod-cone dystrophy was 
noted in all four patients, whereas macular cystic changes were documented in two of 
the four individuals seen at the NIH Clinical Center. Symptoms in this cohort include 
delayed dark adaptation, difficulty with night vision, and visual field deficits. Color vision 
can be affected with macular involvement. Although limited, our data indicated a trend 
towards progressively worse disease in older individuals; those specifically questioned 
indicated worsening of their night and peripheral vision with advancing age.  
 
Gynecologic findings 
Pubertal development was normal in both individuals (P2.1 and P7.1) undergoing 
gynecologic evaluation and age at menarche (12 years and 11.5 years) was similar to 
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that of the general population.15 Both began hormonal treatment (oral contraceptive pills 
or contraceptive patch) at age 16-17 years, one to manage menorrhagia and severe 
dysmenorrhea and the other to regulate her cycles and suppress ovarian cysts. One 
experienced elevated blood pressure on hormonal treatment, prompting discontinued 
use after 1 year. One underwent pelvic examination and pelvic ultrasound, which 
showed a normal-appearing uterus and ovaries that were small but likely proportionate 
to stature. Hormone levels (FSH, LH, estradiol, testosterone, prolactin) were in the 
expected ranges for reproductive-age women. Though neither of the two adult females 
who underwent gynecologic evaluation has tried to conceive, regular menstrual cycles 
and a normal hormone profile suggest no impairment of the ability to conceive.  
 
Growth 
Table S2 demonstrates length/height, weight, head circumference, and body mass 
index as measured by standard deviation scores (corrected for gestational age) 
compared to the general population. Data is presented for individual patients, as well as 
mean and median for all available patients for the first eight years of life. Figure 3 
presents standard deviation scores for length/height of individual patients compared to 
the general population; similar to what occurs in achondroplasia, there is a sharp 
decline in standard deviation scores during the first few months of life, with a final height 
between -4 to -8.5 SD scores.  
 
Skeletal findings 
Representative skeletal features are presented in Figure 4 and supplementary figure 
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S2. Hypoplasia of the odontoid process, overtubulation of long bones with diaphyseal 
narrowing and metaphyseal flaring, and megaepiphyses are universal findings. Oval 
lucencies of the proximal femora are found during infancy. The vertebral bodies are 
initially flat, but become taller with age. The vertebral endplates become more irregular 
with age. Squared-off, ivory epiphyses of the hands are seen in later childhood. Several 
individuals had fractures (4/14, see supplementary figure S3), in at least one case 
without any known trauma, and in other cases after minimal trauma. In addition, one 
had nonunion after surgical osteotomy (supplementary figure S4). Premature 
degenerative joint disease was seen in two adults in their 20s, with early joint 
replacement in one (see supplementary figure S2J). 
 
Laboratory findings 
Asymptomatic elevation of transaminases was noticed in several individuals (see 
supplementary figure S5), without abnormalities in other liver function indices. Aspartate 
aminotransferase (AST) was elevated more often than alanine aminotransferase (ALT). 
Although neutropenia was not appreciated in any person when blood counts were 
obtained within the first two months of life (n=4), it was noted in all individuals for whom 
values were available for analysis (n=12). This neutropenia was intermittent, but did not 
have any noticeable cyclic periodicity. One (P10.1) was receiving chronic granulocyte 
colony stimulating factor (G-CSF) prophylaxis, with reported improvement of counts. 
Response to G-CSF in P13.1 was seen during an episode of orbital cellulitis, with a 
baseline absolute neutrophil count (ANC) of 1080 cells/μL, which improved to 1950 





Frequent misdiagnoses included Wiedemann-Rautenstrauch syndrome (with 
overlapping findings of early progeroid features, poor growth, frontal prominence with 
persistent opening of the anterior fontanelle, prominent scalp veins, a convex nasal 
ridge and thin vermillion of the upper lip), Russell-Silver syndrome (considering the 
short stature, largely of prenatal onset with absence of postnatal catch-up growth, 
relative macrocephaly, large open fontanelle, blue sclerae, and ivory epiphyses), 
Hallermann-Streiff syndrome (given the short stature, cataracts, micrognathia, 
prominent scalp veins and slender diaphyses), pycnodysostosis (given the short stature, 
persistently open fontanelle, short distal phalanges, and nonunion), osteogenesis 
imperfecta (due to blue sclerae, bone fragility and hearing loss), and microcephalic 
osteodysplastic primordial dwarfism type II (due to profound short stature in most cases 
of prenatal onset, microcephaly, low hanging columella, thin bones with metaphyseal 
widening, metacarpal pseudoepiphyses, and ivory phalangeal epiphyses).  
 
A summary of the most common clinical and imaging findings is presented in Figure 5. 
 
DISCUSSION 
Several age-dependent findings emanated from our study of the phenotype of an ultra-
rare disease, Saul-Wilson syndrome. First, although not all patients were born with 
weight or length more than 2SD scores below the mean, all developed short stature 
within the first year of life, and none exhibited any catch-up growth. To put this into 
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perspective, stature was generally lower than the mean for achondroplasia throughout 
their lifetimes. Second, most patients have a progeroid appearance during early infancy. 
The forehead is prominent throughout their lives, but is mainly round in early childhood, 
and becomes tall in late childhood. Blue sclerae are seen during the first few months to 
years of life, but then disappear. Third, neutropenia was not appreciated in the first two 
months of life, but was seen in all tested individuals subsequently. Fourth, the vertebral 
bodies become taller and the endplates irregular with age, while ivory epiphyses 
develop in late childhood. Short distal phalanges of fingers and toes were present from 
birth, and unlike other features, did not appear to change over time.  
 
Bone abnormalities had at least two potential clinical consequences. First, the 
involvement of the epiphyses was a likely cause of osteoarticular pain in all three adult 
patients. In the case of P2.1, degenerative osteoarthritis was objectively diagnosed 
since her early 20s, radiographically and by direct observation at the time of surgery, 
leading to joint replacement on three occasions. P7.1 exhibited advanced degenerative 
changes of the left hip and decreased range of motion of the shoulder joints. Second, 
there is a suggestion of bone fragility, as four patients developed fractures, in at least 
one case with no known underlying trauma, and in another case with poor healing. An 
additional patient exhibited postsurgical nonunion, a finding also reported in the original 
proband in 1982,1 who was not part of our cohort. Other disorders of vesicular trafficking 
are known to lead to bone fragility; these include SEC24D deficiency resulting in a 
syndromic form of osteogenesis imperfecta (OMIM 616294),16 and GORAB deficiency 
associated with geroderma osteodysplasticum (OMIM 231070).17 Recently, a patient 
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with juvenile osteoporosis and recurrent fractures was found to carry a de novo, 
heterozygous variant in COPB2,18 encoding a beta subunit of the Golgi coatamer 
complex that has been shown to interact with different subunits of the COG complex.19 
 
Several ocular manifestations are common in individuals with Saul-Wilson syndrome 
and require attention and specialized care for both the pediatric and adult patient. 
Lamellar cataracts appear to be common and are often noted early in childhood. Further 
investigation of the mechanism underlying the increased risk for cataractogenesis is 
required. Retinal degeneration consistent with a rod-cone dystrophy (retinitis 
pigmentosa) was present in all four patients who underwent detailed ophthalmic exams 
at the NIH Clinical Center; it was also reported in several patients whose records were 
reviewed. The exact mechanism for the occurrence of retinal degeneration in Saul-
Wilson syndrome is not clear; however, other disorders of vesicular trafficking have 
been previously associated with retinal dystrophy, including Cohen syndrome20,21 and 
deficiency of NBAS, a component of the SNARE complex.22  
 
A novel finding in our investigation was elevation of transaminases, although liver failure 
did not develop in any patient. Other intracellular trafficking disorders have been 
associated with liver disease, including SCYL1 deficiency,23 and deficiency of NBAS24 
and RINT125, both subunits of the NRZ complex that participates in retrograde 
trafficking.26 NBAS deficiency is also associated with bone fragility, presumably due to 
reduced collagen secretion,27 while the recurrent liver disease is related to thermal 
susceptibility of the syntaxin 18 complex.28 The latter finding is of particular interest, 
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since different components of the COG complex interact with syntaxins,19 while RINT1 
interacts directly with the COG complex.26  
 
Intermittent neutropenia was noted in all tested individuals. This might explain the 
patients’ frequent respiratory infections in the first years of life, although the neutropenia 
persisted into adulthood while the number of respiratory infections decreased over time. 
Neutropenia is a complication of other disorders of intracellular trafficking, such as 
Cohen syndrome due to VPS13B disease-causing variants,29 severe congenital 
neutropenia type 5 caused by VPS45 variants,30 and adaptor protein complex 3 
deficiency, causing Hermansky-Pudlak syndrome types 2 and 1031; in the latter 
disorders, the neutropenia is thought to be due to impaired intracellular trafficking of 
neutrophil elastase.32 It is thus plausible that the neutropenia of Saul-Wilson syndrome 
could also be related to intracellular mislocalization of proteins.  
 
Based on the identified complications of Saul-Wilson syndrome, we can begin to 
establish recommendations for clinical management. (1) Skeletal – odontoid hypoplasia 
and osteotomy considerations: Given the universal finding of odontoid hypoplasia, with 
frequent C1-C2 subluxation and/or spinal cord compression, best practices in peri-
operative management of patients with skeletal dysplasias should be followed.33 
Skeletal surgery involving osteotomy should only be considered as a last resort, given 
poor healing and nonunion seen in a few patients. (2) Hearing – early evaluation and 
possible hearing aids: Since hearing loss represents a common complication, an 
audiologic evaluation should be performed at least yearly, or as frequently as 
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recommended based on prior findings. Standard treatments for hearing loss (e.g., 
hearing aids) should be offered. (3) Ophthalmologic – cataracts and retinal 
degeneration: The presence of lamellar cataract needs to be assessed by a pediatric 
ophthalmologist and followed up for progression. If the cataract is dense enough to 
require surgery, this needs to be addressed to avoid the risk of amblyopia. Similarly, an 
ophthalmologic evaluation for retinal degeneration is recommended on an annual basis. 
Standard treatments for cataracts, and night blindness (e.g., night vision scopes, 
selected wavelength filters) should be offered. (4) Hematologic – neutropenia and 
possible G-CSF: In the setting of frequent infections, G-CSF prophylaxis should be 
considered, while acute infections in the setting of neutropenia can be managed by 
therapeutic G-CSF administration as needed. (5) Neurologic – hydrocephalus: Two 
patients underwent shunt placement for hydrocephalus. However, another patient with 
communicating hydrocephalus diagnosed in infancy had spontaneous resolution upon 
reimaging at 2 years of age. Thus, the possibility exists that individuals with Saul-Wilson 
syndrome might be predisposed to developing “benign external hydrocephalus”, an 
entity associated with macrocephaly and increased volume of the subarachnoid space 
due to decreased absorption of the cerebrospinal fluid, with spontaneous resolution 
within the first few years of life.34 It is unclear whether a conservative approach is 
indicated in most cases, but insertion of a shunt seems advisable for children showing 
signs of increased intracranial pressure. (6) Nutrition – gastrostomy: Three patients 
underwent gastrostomy tube insertion. This likely represents an attempt by well-
intended physicians to improve the child’s growth; however, overfeeding should be 
avoided. (7) Genetic counseling: Although most individuals show de novo inheritance of 
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the pathogenic variant, sib recurrence was observed in one family (1/13), probably due 
to germline mosaicism in a parent; thus, the recurrence risk in siblings of a proband is 
greater than that of the general population. 
 
In summary, we have carefully delineated the phenotype of Saul-Wilson syndrome, 
providing improved understanding of the morbidity of the disease and allowing for better 
surveillance and management of affected individuals. 
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FIGURE TITLES AND LEGENDS: 
Figure 1. Phenotypic traits of patients with Saul-Wilson syndrome.  
(A-D) Progeroid features seen in the first few months of life (A, P2.1; B, P5.1; C, P6.1; 
D, P7.1). In addition, wrist contractures can be seen in (A), blue sclerae in (A) and (D), 
and boots and bar treatment for clubfoot in (C). (E-H) Facial features seen during early 
childhood (E, P1.1; F, P5.1; G, P6.1; H, P10.1). Note prominent, round forehead with 
prominent scalp veins in all. (I-L) Facial features seen in late childhood (I, P7.1; J, P5.1; 
K, P6.1; L, P10.1). The forehead is still prominent, but mainly tall rather than round. (M-
N) Facial features in adolescence (M, P2.1; N, P7.1). (O-P) Facial features in adulthood 
(O, P2.1; P, P7.1). (Q-T) Feet in P1.1 at 4 years old (Q), P9.1 at 9 years old (R), P7.1 at 
27 years old (S), and P2.1 at 29 years old (T). Note short distal phalanges in all, and 
metatarsus varus in (Q). (U-X) Hands in P1.1 at 4 years old (U), P4.1 at 5 years old (V), 
P9.1 at 9 years old (W), and P7.1 at 27 years old (X). Note short distal phalanges of 
variable degree in all. 
 
Figure 2. Ophthalmologic findings. 
Clinical imaging of the ocular fundus, psychophysical testing, and electroretinography in 
individuals with Saul-Wilson Syndrome. (A) Color fundus photography (CFP) of left eye 
of P1.1 obtained under anesthesia using a portable device (RetCam3) and showing 
mottling of the retinal pigment epithelium (yellow arrows) and an elevated lesion inferior 
to the optic nerve head (white arrow). Image clarity is reduced by the presence of 
lamellar cataract. (B) Bioptigen optical coherence tomography indicates preserved 
central retina including absence of macular cystic changes and normal ellipsoid zone 
 
 24 
(EZ) layer in P1.1. (C, F) CFP of the right and (I) left eye of affected individuals showing 
characteristic features of rod-cone dystrophies including attenuated retinal vessels, 
waxy pallor of optic nerve head, and midperipheral bony spicules (yellow arrowheads) 
(C, P2.1; F: P7.1; I: P10.1). (D, G) Fundus autofluorescence (FAF) images of the right 
eye and (J) left eye of affected individuals showing pigment deposition as 
hypoautofluorescence (yellow arrowheads) and a characteristic hyperautofluorescence 
ring (white arrowheads) typically seen in rod-cone dystrophies (D: P2.1; G: P:7.1; J: 
P10.1). (E, H) Cirrus optical coherence tomography scans of the right eye and (K) left 
eye of affected individuals ranging from an almost normal scan in (E) to loss of ellipsoid 
zone EZ-band (yellow arrowheads) in (H) as well as presence of macular cystic 
changes in (H, K) (white arrowheads) (E: P2.1; H: P7.1; K: P10.1). (L, M) Kinetic 
perimetry of P2.1 and P7.1, respectively, showing different degrees of constriction and 
midperipheral scotomata. (N) Representative electroretinography (ERG) from P2.1 
showing a reduction and delay of the scotopic responses to a greater degree than the 
photopic ones, confirming the presence of a rod-cone dystrophy. 
 
Figure 3. Length/height expressed as standard deviation scores. 
Note a sharp decline in SD scores during the first few months of life, with an eventual 
plateau around -4 to -8.5 SD scores. Growth is near or below the mean stature for 
achondroplasia (dashed line).  
 




(A-E) Radiographs of lateral cervical spine in P4.1 at 8 months (A), P5.2 at 1 year 11 
months (B), P3.1 at 2 years 6 months (C), P5.1 at 6 years 1 month (D), and P7.1 at 11 
years 6 months (E). Note hypoplasia of the odontoid process in all (arrows). (F-J) 
Radiographs of lateral lumbar spine in P4.1 at 3 months old (F), P6.1 at 5 years 10 
months (G), P5.1 at 6 years 7 months (H), P10.1 at 9 years 3 months (I), and P9.1 at 12 
years 5 months (J). The vertebral bodies become taller and more irregular with age. 
Note hypoplasia of L1 in (G, H, I). (K-O) Radiographs of lower extremities in P7.1 at 23 
days (K), P10.1 at 9 weeks (L), P8.1 at 6 months (M), P5.2 at 3 years 10 months (N), 
and P9.1 at 12 years 5 months (O). Note proximal femoral lucencies in the first few 
months of life (arrows), as well as overtubulation of the long bones with slender 
diaphyses and metaphyseal flaring in all. (P-T) Radiographs of hands in P4.1 at 3 
months (P), P13.1 at 13 months (Q), P6.1 at 6 years 9 months (R), P9.1 at 9 years 8 
months (S), and P6.1 at 10 years (T). Note shortening of metacarpals and phalanges 
and cone-shaped epiphyses of the phalanges in all, accessory ossification centers of 
the proximal metacarpals (Q, R, T), and the development of squared-off ivory epiphyses 
(arrows) in late childhood (S, T).  
 
Figure 5. Relative frequency of clinical and radiographic findings in Saul-Wilson 
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Appendix 1. Patient summaries. 
 
Patient 1.1 
This boy was born to nonconsanguineous Caucasian parents of average height.  
Intrauterine growth retardation was diagnosed at 20 weeks’ gestation, leading to 
induced vaginal delivery at 36 weeks’ gestation. Birth weight was 2,200 grams 
(CDC Z-score= -2.2; Fenton Z-score= -1.2), birth length of 43.1 cm (CDC Z-
score= -2.6; Fenton Z-score= -1.7), and birth occipitofrontal circumference (OFC) 
of 32.7 cm (CDC Z-score= -1.4; Fenton Z-score= 0.0). At birth, talipes 
equinovarus was noted, along with a progeroid appearance, frontal prominence 
with an enlarged anterior fontanelle, prominent eyes, blue sclerae, 
telebrachydactyly, and micrognathia. Clubfoot was treated with serial casting. 
The infant failed his newborn hearing screen, and a temporal bone CT scan at 4 
months of age showed a dysplastic cochlea, dilated and bulbous internal auditory 
canals, and mildly dilated vestibules and semicircular canals. During infancy he 
could only tolerate small volumes of formula, or he would otherwise regurgitate. 
At 6 months of age, non-obstructive ventriculomegaly was diagnosed, and at one 
year stenosis of the foramen magnum. During childhood, he was found to have 
bilateral lamellar cataracts, mild nystagmus, and an asymptomatic subaortic 
septal thickening without aortic valve stenosis. He had recurrent ear infections 
requiring myringotomy tubes three times due to ear drainage. He sat unassisted 
at 15 months, army crawled at 16-18 months, and walked at 24 months. He 
remained largely nonverbal until approximately 4 years of age, but 
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communicated effectively using a few hundred signs. An endocrinologic 
evaluation provided no indication that growth hormone secretion was deficient, 
and growth hormone supplementation did not lead to an increased growth 
velocity. 
 
At the age of 4 years 4 months, Patient 1.1 was evaluated at the NIH Clinical 
Center. Despite his absolute microcephaly, his frontal prominence and more 
severely affected height and weight growth parameters imparted a clinical 
impression of relative macrocephaly. He had a high-pitched voice and an 
appearance of generalized lipodystrophy with prominent veins, particularly over 
the lateral forehead. Audiologic evaluation revealed a mild-to-moderate hearing 
loss that was mixed for the low-to-mid frequencies and sensorineural for the high 
frequencies in the left ear, with a slightly rising moderate-to-moderately severe 
mixed hearing loss for the entire frequency range in the right ear. Neuroimaging 
revealed the interval growth of a soft tissue pannus surrounding the odontoid 
process of the axis, resulting in severe stenosis of the central spinal canal at the 
level of C1, but with no abnormal signal of the spinal cord. An ophthalmologic 
evaluation revealed night blindness, and optical coherence tomography 
confirmed peripheral retinal atrophy. He also had marked optic nerve elevation, 
thought to be either pseudopapilledema from optic nerve shortening, or true 
papilledema from increased intracranial pressure. On formal neurodevelopmental 
evaluation, despite a previous diagnosis of global developmental delay, several 
of his cognitive skills were in the average range for his age. In fact, he presented 
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a complex and varied profile with greatest challenges in the domains of language 
(receptive, expressive, and verbal comprehension) and processing speed; visual 
spatial skills and working memory skills were areas of strength. 
 
Patient 2.1 
The clinical and radiographic findings of this Caucasian patient, until the age of 4 
years 8 months, were previously reported.1 In summary, she was born at term 
with bilateral clubfoot treated with serial casting, and a diagnosis of neonatal 
progeria was initially entertained. For the first few months of life she exhibited 
feeding difficulty, hypotonia and mild gross motor delays. She developed 
recurrent otitis media necessitating myringotomy tubes, initially placed at 8 
months old. A spinal MRI at 2 years of age showed a lumbosacral syrinx and 
tethered cord, the latter requiring a surgical release. Lamellar cataracts were 
diagnosed at 2 years old, and at that time a diagnosis of Hallermann-Streiff 
syndrome was entertained. She underwent left lens extraction at 3 years old. She 
underwent left clubfoot repair at 2 years old, and required multiple surgical 
revisions at 3, 9 and 12 years old. At the age of 14 years, she was diagnosed 
with cervical spine instability with compression of the spinal cord at C1, 
necessitating a cervical spine fusion. She underwent gingival graft for recession 
at the ages of 16 and 18 years. At 17 years of age, she was started on oral 
contraceptives for ovarian cysts, and at the same age was diagnosed with night 
blindness. At 21 years of age, she developed acute right shoulder pain and was 
given a diagnosis of degenerative joint disease, necessitating total shoulder 
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arthroplasty at 22 years of age; at the time of surgery, pertinent findings included 
bone-on-bone articulation between the humeral head and glenoid, and numerous 
subchondral cysts of the glenoid. Similarly, at 25 years of age she underwent a 
right hip arthroplasty, and then at 26 years, a left shoulder arthroplasty. At 22 
years of age she was diagnosed with osteoporosis and received weekly 
alendronate, which she continued for the next six years before switching to 
teriparatide for one year. In retrospect, however, her low bone mineral density on 
dual-energy X-ray absorptiometry (DXA) seemed falsely low, as the height-
corrected bone mineral density was normal even before initiation of treatment. At 
age 23, she graduated college. At age 24, she was diagnosed with mild-to-
moderate bilateral sensorineural hearing loss, which has remained stable over 
time. An ophthalmologic evaluation at 29 years of age revealed bilateral cone-rod 
dystrophy with pigmentary retinopathy. Wechsler Adult Intelligence Scale - 
Fourth Edition (WAIS-IV) showed a full-scale IQ of 82 (m=100, SD=15). Her 




This boy was the 3rd child to a nonconsanguineous couple of average height and 
German descent. He was born at 37 weeks 2 days’ gestation, with a birth weight 
of 1,850 grams (CDC Z-score= -2.7; Fenton Z-score= -2.8), birth length of 44 cm 
(CDC Z-score= -2.3; Fenton Z-score= -1.9), and birth occipitofrontal head 
circumference of 30 cm (CDC Z-score= -2.6; Fenton Z-score= -2.4). Placental 
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weight was only 460 gm, without infarcts. At birth, he was noted to have a large 
fontanelle, low-set ears, periorbital edema, small thorax, right-sided hydrocele, 
and clinodactyly of the fifth fingers. Ultrasound exams of the head, hips and 
kidneys were unremarkable. He had a 3-week neonatal hospital stay due to 
feeding difficulties. A possible diagnosis of Russell-Silver syndrome was 
entertained at the time.  
 
At age 3 months, he underwent a gastrostomy tube insertion to increase caloric 
intake, and had repeated upper airway infections associated with obstructive 
sleep apnea. Over time, he developed prominent scalp veins and relative 
macrocephaly. Hydrocephalus was suspected, but a repeat head ultrasound 
revealed no ventriculomegaly. Nearly no expressive language was observed 
during the first two years. Hearing evaluations were difficult to interpret given the 
inability to perform otoacoustic emissions, as well as frequent airway infections, 
but he was deemed to have normal hearing. He also had motor delays, as at 13 
months, he was still unable to sit independently. He was also noted to have thin 
skin with lack of subcutaneous fat, and he exhibited severe growth delay. He 
continued to have feeding difficulties with poor intake, necessitating ongoing use 
of his gastrostomy tube.  
  
During the first few years of life he developed frequent upper and lower 
respiratory infections, some of them associated with elevated CRP 
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concentrations and leukopenia. Neutropenia was observed, although anti-
neutrophil antibodies were not found.  
 
Ophthalmologic exam revealed bilateral hyperopia (+4 diopters) and bilateral 
pseudopapilledema; there were no signs of increased intracranial pressure. At 20 
months of age, intermittent right-sided horizontal nystagmus was observed, but 
resolved spontaneously. He was diagnosed with bilateral cortical cataracts at the 
age of 7 years, and a surgical procedure is being planned in the near future.  
 
At the age of 5 years he developed acute idiopathic thrombocytopenic purpura 
with intraoral bleeding, which was treated with platelet transfusions, intravenous 
immunoglobulin, and steroids. Given the prior episodes of neutropenia and now 
thrombocytopenia, a bone marrow biopsy was performed, and was 
unremarkable.  
 
He started elementary school at the age of 7 years. By then, his motor 
development had improved significantly. His speech improved dramatically after 
school enrollment, although he uses mostly 2-3 word sentences, and his speech 
still remains somewhat unintelligible. His cognitive function, and especially 




This girl is the only child of a nonconsanguineous couple of Brazilian descent. 
The father had congenital bilateral clubfoot. The girl was conceived via in vitro 
fertilization due to reduced paternal sperm motility. The pregnancy was 
complicated by maternal hypertension from 21 weeks’ gestation. Prenatal 
ultrasound revealed intrauterine growth restriction at 24 weeks’ gestation, with 
shortened femora and humeri. The patient was born at 36 weeks’ gestation via 
Caesarean section, with Apgar scores of 8 and 9 at 1 and 5 minutes, 
respectively. Birth weight was 1,450 grams (CDC Z-score= -3.8; Fenton Z-score= 
-3.0), birth length was 38 cm (CDC Z-score= -5.1; Fenton Z-score= -3.3), and 
birth occipitofrontal head circumference was 29 cm (CDC Z-score = -3.9; Fenton 
Z-score= -2.2). The patient remained in the neonatal intensive care unit for 38 
days due to poor weight gain. Right talipes equinovarus was noted at birth, and 
treated with serial casting, followed by an Achilles tenotomy at 3 months of age. 
At 3 months of age she exhibited severe growth failure, relative macrocephaly 
with triangular facies, brachycephaly, broad forehead, biparietal prominence, 
enlarged anterior fontanelle, proptosis, and rhizomelic shortening of the upper 
extremities. A head CT scan at 3 months of age disclosed a benign subdural 
effusion. An ophthalmologic evaluation at 5 months of age revealed bilateral 
hyperopia (OD +3.00, OS +3.75). At 1 year of age, she had diffuse reduction of 
subcutaneous adipose tissue, prominent veins in the scalp and abdomen, and 
sparse hair and eyebrows. She started walking at 20 months of age, and her 
anterior fontanelle closed by 21 months of age. She had four episodes of otitis 
media between 2 and 4 years of age. At 4 years old, she had increased thoracic 
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kyphosis, restriction of elbow extension, enamel defects, some degree of speech 
delay, and a hypernasal voice. At 7 years of age, her height was 82 cm (Z= -4.9), 
weight 9.49 kg (Z= -77, occipitofrontal circumference 48.5 cm (Z= -2.4), arm span 
73 cm, and sitting height 45.5 cm. By the last examination, she had bilateral 




This boy was conceived to nonconsanguineous Caucasian parents of average 
height. Pregnancy was complicated by intrauterine growth retardation and left 
hydronephrosis. Delivery was by emergent Caesarean section at 37 weeks’ 
gestation due to non-reassuring fetal heart rate. Birth weight was 2,240 grams 
(CDC Z-score= -2.1; Fenton Z-score= -1.6), birth length was 48.3 cm (CDC Z-
score= -0.7; Fenton Z-score= 0.0), and birth occipitofrontal head circumference 
was 33 cm (CDC Z-score= -1.3; Fenton Z-score= -0.2). He failed his newborn 
hearing screen and received phototherapy for jaundice in the newborn nursery. 
He underwent casting at 3 days of age for right clubfoot, and was discharged to 
home at 5 days of age. He had a ventriculoperitoneal shunt placed at 6 months 
of age for hydrocephalus, and a gastrostomy tube placed at 8 months of age. 
 
He had many hospitalizations in his first 2 years of life for pneumonia, RSV, and 
other respiratory infections. An endocrinologic evaluation at 5 years of age noted 
only low IGF1 levels; he passed two growth hormone stimulation tests at 6 and 7 
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years of age. He was admitted at 7 years of age for left ureteropelvic junction 
obstruction secondary to constipation, treated with bowel cleanout. Myringotomy 
tubes were placed multiple times, last at 7 years of age, due to chronic effusions 
bilaterally leading to conductive hearing loss. He had an adenotonsillectomy at 7 
years of age due to recurrent streptococcal pharyngitis. An immunologic 
evaluation noted normal IgG, IgA, IgE, and IgM levels and normal diphtheria and 
tetanus titers. Intermittent neutropenia prompted a bone marrow aspiration, 
which yielded unremarkable results. Dental evaluation revealed advanced 
eruption of secondary teeth; a molar had erupted by 8 years of age. Also at 8 
years old, he underwent surgical treatment for ureteropelvic junction obstruction.     
 
Developmentally, he started walking at 2 years of age. At age 8 years he is doing 
well in school and reading above grade level. 
 
 At his last clinical evaluation at age 8 years, he had mild-to-moderately severe 
conductive hearing loss, slightly worse on the right side, with hearing grossly 
normal for conversation. He had developed bilateral cataracts and exhibited 
bilateral exophoria, myopia, anisometropia, and an anatomical narrow angle. He 
did not have any acute or chronic joint pain. He was grossly normocephalic with 
bifrontal bossing, and a triangular facies; the external scalp vessels were visible. 
The sclerae were white and not injected; palpebral fissures were horizontal. 
External ears had normal structure and position. The teeth appeared to be of 
mixed dentition, with dental crowding. From the musculoskeletal standpoint, 
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there was proportionate short stature with anterolateral rib flaring. Clinically, there 
was no evidence of scoliosis, kyphosis or lordosis. Elbows lacked approximately 
40 degrees from full extension, but otherwise range of motion at the elbows, 
wrists and knees was full. Telebrachydactyly was noted, and the left fourth and 
fifth fingers showed camptodactyly. Pes planus was noted. His neurologic 
examination was normal.  
 
Patient 5.2 
This male is a full sibling to patient 5.1. Pregnancy was complicated by 
gestational diabetes treated at first by diet and then with oral medication in the 
third trimester. Prenatal monitoring noted supraventricular tachycardia, for which 
his mother was treated during the late second to early third trimester, and 
admitted for 3 weeks of the pregnancy. Polyhydramnios was noted in the second 
trimester. Delivery was by emergent Caesarean section at 32 weeks 4 days’ 
gestation due to non-reassuring fetal heart tones and failure to progress. Birth 
weight was 1,750 grams (CDC Z-score= -2.9; Fenton Z-score= -0.4), birth length 
was 41 cm (CDC Z-score= -3.4; Fenton Z-score= -0.7), and birth occipitofrontal 
head circumference was 31.5 cm (CDC Z-score= -1.9; Fenton Z-score= 1.1).  
Supraventricular tachycardia was not present after birth. The infant had normal 
head ultrasound exams in the nursery, where he had an extended stay due to 
prematurity. He failed his newborn hearing screen due to conductive loss. He 
was discharged to home at 5 weeks of age. 
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Multiple myringotomy tubes were placed for chronic mucoid and serous effusion, 
with concurrent adenoidectomy. There were no further surgeries, but he did have 
a femur fracture after falling off a swing at 2 years old, which was treated with 
reduction and a spica cast. His anterior fontanelle was still open at 2.5 years of 
age, measuring 4x4 cm. 
 
 At his last clinical evaluation at 3 years 10 months of age, he wore glasses due 
to hyperopia and accommodative esotropia (OD +3.50, OS +3.00+00.50x139); 
no cataracts were detected. He was grossly normocephalic with bifrontal bossing 
and triangular facies. The fontanelles were closed. The external scalp vessels 
were visible, but not prominent. The sclerae were white and not injected; 
palpebral fissures were horizontal. External ears had normal structure and 
position. Dental crowding was present. From the musculoskeletal standpoint, 
there was proportionate short stature. Clinically, there was no evidence of 
scoliosis, thoracolumbar kyphosis, or lordosis. Elbows lacked approximately 
40 degrees from full extension, but otherwise range of motion at the elbows, 
wrists and knees were full. Telebrachyphalangy was noted. Pes planus was 
noted. Neurologic examination was normal.   
 
Patient 6.1 
 This boy was born at 37 weeks’ gestation to nonconsanguineous Caucasian 
parents. Pregnancy was complicated by intrauterine growth restriction with short 
femurs noted in the third trimester. Birth weight was 2,180 grams (CDC Z-score= 
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-2.2; Fenton Z-score= -1.8), birth length was 45.5 cm (CDC Z-score= -1.7; 
Fenton Z-score= -1.2) and birth occipitofrontal circumference was 30.5 cm (CDC 
Z-score= -2.4; Fenton Z-score= -1.9). He exhibited talipes equinovarus and a 
disproportionately large head with prominent scalp veins. He spent time in the 
neonatal intensive care unit due to respiratory distress and failure to gain weight. 
He received serial casting for talipes equinovarus and subsequently underwent 
heel cord tenotomy. He also had a tethered cord, and ultrasound performed 
shortly after birth showed bilateral mild-to-moderate hydronephrosis, which 
resolved spontaneously. He passed his newborn hearing screen but failed a 
sedated auditory brain response exam (bilaterally) at 6 months of age.  
 
A brain MRI obtained at 5 months of age showed communicating hydrocephalus.  
Follow-up MRI at 2 years of age showed resolution of the hydrocephalus without 
other anomalies. During infancy he had frequent neutropenia with negative anti-
neutrophil antibody testing, associated with bouts of pneumonia that resolved by 
the age of 2 years. His anterior fontanelle was still open at 3 years of age. 
Recurrent otitis media prompted placement of myringotomy tubes at 3 years of 
age. A prior history of speech delay required speech therapy, but he is currently 
doing well in school with no cognitive problems, and he does not require any 
specialized therapies. He was followed by cardiology for a patent foramen ovale 
and had aortic dilation on echocardiogram. At 9 years 11 months of age, his 
aortic annulus measured 1.72 cm (Z-score 2.57), aortic root 2.33 cm (Z-score 
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2.5), sinotubular junction 1.90 cm (Z-score 1.85) and ascending aorta 2.30 cm 
(Z-score 3.24).  
 
Ophthalmologic evaluation identified hyperopia and cataracts, requiring bilateral 
phakectomy. The patient has received growth hormone supplementation since 3 
years of age at a dose 0.23-0.36 mg/kg/week, with modest improvement in 
height. 
 
A diagnosis of microcephalic osteodysplastic primordial dwarfism type 2 was 
postulated based on review of radiographs. Other diagnoses entertained over the 
course of his life included progeria, Wiedemann-Rautestrauch syndrome, 
mandibuloacral dysplasia, Seckel syndrome, Russell-Silver syndrome, 
Hallermann-Streiff syndrome, and Meier-Gorlin syndrome.  
 
Developmental assessment at 9 years of age using the Reynolds Intellectual 
Assessment Scales showed a verbal intelligence index of 104, nonverbal 
intelligence index of 118, composite memory index of 115, and composite 
intelligence index of 111.  
 
At age 10 years, the boy had a 9-degree dextrocurvature of the upper thoracic 
spine (T2-T6) and 4-degree levocurvature of the midthoracic spine (T6-T9), with 
11-degree levoscoliosis of the thoracolumbar spine (T9-L2) and 9-degree 
levocurvature of the lumbar spine (L2-L5). 
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At the age of 11 years, he exhibits bilateral conductive hearing loss, for which he 
wears hearing aids.  
 
Patient 7.1 
This Caucasian girl was delivered at 39 weeks’ gestation via Caesarean section, 
after a pregnancy complicated by oligohydramnios from 2.5 weeks of amniotic 
fluid leak prior to delivery. Her birth weight was 1,960 grams (CDC Z-score= -2.8; 
Fenton Z-score= -3.2). At the time of delivery, she had contractures of her 
elbows, knees and calcaneovalgus deformities of her feet, which resolved 
spontaneously over the next few weeks, except for some mild restriction of elbow 
and knee extension that persisted over the years. She had several apneic 
episodes that had resolved by two weeks of life. A physical exam at 3 weeks of 
life revealed a distinctive appearance with translucent skin over her face and 
head with prominence of the veins, midface hypoplasia with shallow orbits and 
exophthalmos, a prominent nasal bridge with slight beaking of the tip of the nose, 
and an enlarged anterior fontanelle. As a toddler, she had recurrent otitis media, 
and was diagnosed with high myopia. Diagnoses that were initially entertained 
included pycnodysostosis, osteogenesis imperfecta, and Hallermann-Streiff 
syndrome. At 5 years of age, she was clinically diagnosed with Saul-Wilson 
syndrome, at which time her height was 85 cm, weight 10.7 kg, and head 
circumference 49 cm. She had wedging of T12 and odontoid hypoplasia with 
some instability (4 mm of translation), mild pectus carinatum, mild thoracic 
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kyphosis, and short distal phalanges. She had pigmentary changes of the retina 
that spared the macula but produced a blotchy appearance of the retinal 
periphery. At 6 years of age her refractive error was -3.00 -.25 x 30 OD and -4.00 
-2.25 x 30 OS. At 13 years old she received hearing aids for moderate-to-severe 
conductive hearing loss in the right ear, and moderate-to-profound conductive 
hearing loss in the left ear. She was found to have tympanosclerosis with 
ossicular fixation.  
 
Surgical history included myringotomy tube placement and adenoidectomy by 5 
years of age, and left tympanoplasty at 13 years of age. Also at 13 years of age 
she underwent bilateral shelf acetabuloplasty and bilateral femoral varus 
osteotomy to treat severe bilateral acetabular dysplasia that had caused 
disabling hip pain. At age 16, she had a hip revision due to nonunion on the right 
side leading to pain; this included repeat osteotomy of the right proximal femur 
with debridement of pseudoarthrosis. Five months later she had further revision 
of the right proximal femoral nonunion. She had bilateral cataract removal at 21 
years of age. 
  
At 23 years of age, she had leg length discrepancy; her height was 107.1 cm and 
her head circumference was 51.4 cm. She avoided hard foods because her 
widely spaced teeth felt loosely anchored. She wore hearing aids and lacked 
peripheral vision. Physical exam at 27 years of age also revealed limited 
shoulder range of motion, to only about 75 degrees of abduction bilaterally, while 
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hip radiographs revealed advanced degenerative changes of the left hip. A DXA 
scan showed a Z-score of the anteroposterior spine (L2-L4) of -5.2 and a right 
1/3 forearm Z-score of -1.1, but Z-score correction for height (assuming 20 years 
of age, the upper age limit allowed for this correction) corresponded to -2.48 in 
the lumbar spine, and +0.85 in the 1/3 radius.2 Wechsler Adult Intelligence Scale 
- Fourth Edition (WAIS-IV) showed a full-scale IQ of 89. Scores in the Wide 
Range Achievement Test - 4 (WRAT4) were 79 for word reading, 81 for sentence 




This boy is the first child of healthy Swedish parents of average height. 
Pregnancy was complicated by intrauterine growth retardation and talipes 
equinovarus diagnosed at 19 weeks’ gestation. He was born vaginally at 41 
weeks’ gestation, with birth weight of 2,800 grams (CDC Z-score= -1.2; Fenton Z-
score= -2.2), birth length of 46 cm (CDC Z= -1.6; Fenton Z-score= -2.8), and birth 
occipitofrontal head circumference of 33.5 cm (CDC Z-score= -1.1; Fenton Z-
score= -1.5). The boy had mild neonatal jaundice and persistent feeding 
difficulties. His talipes equinovarus was treated with tenotomy of the Achilles 
tendon and a Mitchell-Ponseti abduction brace, which he still wears at night. He 
has no ocular manifestations. Neonatal hearing test was normal. He had a heart 
murmur, but echocardiogram was normal. His motor development was slightly 
delayed and he sat at eight months of age. 
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On his last exam at 9 months of age, the boy had relative macrocephaly, frontal 
bossing with an indentation in the middle of the forehead, a prominent vascular 
network over the skull and a large anterior fontanelle (15x15 cm). He exhibited 
widely spaced eyes, long eyelashes and slight proptosis. Midface hypoplasia was 
present, with relatively large ears, retrognathia, and small mouth with thin lips 
and downturned corners of the mouth. Heart sounds were normal. He has a 
protuberant abdomen–but no organomegaly or umbilical hernia–and a shawl 
scrotum. His first metacarpal was a bit short and his fingers had a slight ulnar 
deviation with normal nails. Range of motion of the extremities was normal 
throughout, with slight overextension of the knees. His back was straight, with a 
small sacral dimple, but no hypertrichosis.  
 
Patient 9.1 
This girl was born to Canadian parents of average stature. Pregnancy was 
complicated by maternal insulin-dependent diabetes mellitus and prenatal 
ultrasound revealing bilateral shortened femurs at 31 weeks’ gestation. She was 
born at 36 weeks’ gestation, with birth weight of 2,130 grams (CDC Z-score= -
2.5; Fenton Z-score= 2.0), birth length of 39 cm (CDC Z-score= -4.7; Fenton Z-
score= -0.3), and birth occipitofrontal head circumference of 30.5 cm (CDC Z-
score= -2.9; Fenton Z-score= 1.8). At birth, physical exam showed a widely 
patent anterior fontanelle measuring 8x7 cm, bilateral proptosis, downslanted 
palpebral fissures, micrognathia, and low-set ears.  
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Early developmental milestones were achieved on time; there were no 
developmental or hearing concerns. She was diagnosed with strabismus and 
myopia and was prescribed glasses at one year of age. She has peripheral vision 
loss. There are no known cardiac concerns. She was diagnosed with 
growth hormone deficiency on stimulation testing; growth hormone therapy was 
eventually stopped due to limited linear growth response. 
 
At her last exam at 9 years of age, she exhibited downslanted palpebral fissures, 
bulbous nose, short neck, and a prominent metopic ridge. Her ears were 
normally formed, but low-set. She had proportional short stature with acromelia. 
Her hands were short and broad, with extremely short and broad fingers and 
redundant skin. She exhibited genu valgum, pes planus, overpronation of the 
ankles and feet and short, broad toes. She also displayed significant lumbar 
lordosis. Cardiorespiratory, abdominal, and neurologic exams were 
unremarkable.  
 
A brain MRI incidentally identified a well-defined arachnoid cyst filling the sella 
and compressing the pituitary gland. Her echocardiogram was normal. A skeletal 
survey showed diffuse broadening and shortening of all phalanges, metatarsals 
and metacarpals. Her tibiae and fibulae had prominent proximal and distal 
metaphyses and epiphyses. There were also prominent distal metaphyses and 
epiphyses of her femurs. The iliac bones were mildly diminutive, but with normal 
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morphology. The hips exhibited mild broadening of the proximal femoral 
epiphyses and metaphyses. The vertebral bodies showed anteroinferior beaking 
in the thoracolumbar region, with no gibbus deformity. There was mild 
dextroscoliosis of the thoracolumbar spine. She had a J-shaped sella and 
innumerable Wormian bones. Her overall bone density was satisfactory, and her 
bone age was at the lower range of normal. 
 
Patient 10.1 
This boy is the first child of healthy nonconsanguineous Danish parents of 
average height. He was born at 40 weeks’ gestation via Caesarean section due 
to breech presentation. Apgar scores were normal. Birth weight was 2,780 grams 
(CDC Z-score= -1.3; Fenton Z-score= -1.8), birth length was 49 cm (CDC Z-
score= -0.4; Fenton Z-score= -1.0), and birth occipitofrontal head circumference 
was 34 cm (CDC Z-score= -0.8; Fenton Z-score= -0.7). He had a large anterior 
fontanelle extending to the nasal bridge, a prominent forehead, low-set ears, 
contractures at the elbows and knees, and clubfoot. He developed severe failure 
to thrive during the first few weeks of life. At 4 months of age, a 
ventriculoperitoneal shunt was placed. He underwent bilateral cataract surgery at 
9 months, and gastrostomy tube placement at 15 months of age. He sat 
independently at 9 months of age, and walked independently by 2 years of age. 
He was noted to have neutropenia associated with recurrent infections and 
requiring filgrastim administration, and additionally had hepatosplenomegaly. A 
bone marrow biopsy at 2 years of age showed a hyperplastic marrow; a liver 
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biopsy showed eosinophilic inclusions. He had a renal stone at 2 years 4 months 
old. He also had vitreoretinal degeneration, and wears a bone-anchored hearing 
aid for right-sided hearing loss. Imaging studies revealed a normal 
echocardiogram, normal DXA scan, head CT scan with open sutures, delayed 
cranial vault ossification, and subluxation of the atlas, and brain MRI with delayed 
myelination, hypoplastic corpus callosum, small cysts in the capsula interna, and 
anterior displacement of the atlas with an abnormal course of the proximal 
cervical medulla oblongata and pons. Methylation analysis for Russell-Silver 
syndrome was normal. 
 
At 5 years 7 months, he developed a mid-diaphyseal fracture of the left femur 
after slipping on the floor, which was considered a low-impact fall. At 10 years 8 
months of age, his weight was 16 kg (Z= -3.9), height 105 cm (Z= -5.4), and head 
circumference 51 cm (Z= -1.5).  
 
Patient 11.1 
This girl was born to healthy parents of Mexican descent. Pregnancy was 
complicated by asymmetric intrauterine growth retardation. She was born via 
vaginal delivery at 37 weeks 5 days’ gestation, with birth weight of 1,810 grams 
(CDC Z-score= -3.1; Fenton Z-score= -3.0) and birth length of 42 cm (CDC Z-
score= -3.3; Fenton Z-score= -2.6). She had a single umbilical artery, left-sided 
grade 3 hydronephrosis, and a patent ductus arteriosus that closed 
spontaneously. She stayed in the neonatal intensive care unit for poor weight 
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gain. She had bilateral clubfoot, and received serial casting followed by Achilles 
tenotomies at 11 months of age; at 23 months old, she still wears a boots and 
bar orthosis at night.  
 
Her motor development has been delayed. She sat independently at 18 months 
and pulled to stand at 22 months old. At 23 months, she cannot crawl. She 
speaks two words. Her fine motor and social development appear normal.  
 
She passed her newborn hearing screen, but speech audiometry performed at 
22 months of age revealed abnormal responses to speech stimuli in the 
moderate hearing loss range, in at least one ear, on soundfield testing. She had 
otitis media and frequent upper respiratory infections. Her white blood cell count 
at 18 months of age was 5,510 cells/uL, with 6.2% neutrophils (absolute 
neutrophil count of 340/uL). Additionally, she had increased TSH and received 
levothyroxine supplementation at 18 months of age.  
 
Physical examination at 23 months of age revealed an enlarged anterior 
fontanelle (8x4 cm), prominent forehead and scalp veins, low-set ears, prominent 
eyes with bluish sclerae, a thin nasal bridge with a convex nasal ridge inferiorly, 
and a prominent columella. There was a prominent groove along the inferior 
border of the rib cage, but no pectus deformity; a mild thoracolumbar gibbus was 
present, as well as lateral elbow prominence bilaterally and distal joint laxity. Of 
note, there was no telebrachydactyly. 
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A diagnosis of Lenz-Majewski syndrome had been entertained on clinical 
grounds, while a diagnosis of microcephalic osteodysplastic primordial dwarfism 




This male Caucasian subject, now age 39 years, was previously described as 
patient 2 by Saul and Wilson3, along with an unrelated older patient who had 
similar physical and radiographic findings 
  
He was born at 36 weeks’ gestation, with birth weight 1.5 kg (CDC Z-score= -3.3; 
Fenton Z-score= -2.9). At birth, he was noted to have a large anterior fontanelle 
(7x7 cm), bilateral clubfoot, a prominent sternum, and knee and elbow 
contractures. His early weight gain and linear growth were slow, and his 
developmental milestones were delayed. He crawled at 12 months, walked at 3 
years, and had delayed language development. Early hearing tests were normal, 
but he was subsequently found to have conductive hearing loss. He had frequent 
ear infections, and a benign cholesteatoma was removed at age 7 years. He had 
several focal seizures with normal EEG studies. 
 
At 9 years of age, his height was 96.5 cm, weight 16.1 kg, and head 
circumference 48.9 cm. He had a prominent forehead, a narrow nasal root with a 
“beaked” nose, and prominent globes. His chin was small, and the teeth were 
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crowded and slightly opalescent. Testes were palpable high in the scrotum. The 
hands and fingers were short, and the fingers were broad distally, with short 
nails. Radiographs showed short, broad phalanges with coning and sclerosis of 
several phalangeal epiphyses. Although earlier bone age determinations were 
delayed, bone age determination at age 8 years was normal. There was delayed 
closure of his anterior fontanelle. An ophthalmologic exam at age 8 years was 
normal, but he subsequently developed mild cataracts. 
 
He has had several episodes of pneumonia requiring hospitalization and has had 
intermittent neutropenia. He had a traumatic fracture of his femur at age 12 years 
and another femoral fracture at age 25 years that was complicated by poor 
healing, and he eventually needed a wheelchair. Currently, he receives opioids 
regularly for osteoarticular pain. 
 
Patient 13.1 
This girl was the second child of a nonconsanguineous couple of average height 
and Korean descent. Pregnancy was complicated by intrauterine growth 
retardation, fetal micromelia, poorly mineralized cranium and distal spine, flat 
nasal bridge, and bilateral clubfoot. She was born at 39 weeks’ gestation via 
vaginal delivery, with Apgar scores of 7 and 9 at 1 and 5 minutes, respectively. 
Birth weight was 2,150 grams (CDC Z-score= -2.4; Fenton Z-score= -2.6), birth 
length 45 cm (CDC Z-score= -2.0; Fenton Z-score= -1.9), and birth occipitofrontal 
head circumference 32 cm (CDC Z-score= -1.9; Fenton Z-score= -1.5). Physical 
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exam revealed large anterior fontanelle, short palpebral fissures, mild ptosis, 
malar hypoplasia, small mouth, low-set cup-shaped ears, and short limbs. She 
remained in the neonatal intensive care unit for 8 days due to mild respiratory 
distress and feeding problems. Head and renal ultrasound exams and 
echocardiogram were unremarkable, and she passed the newborn hearing 
screen. Brain MRI revealed normal sized ventricles and a cavum septum 
pellucidum. Bilateral talipes equinovarus was treated by serial casting followed 
by heel cord lengthening. She suffered a right humeral fracture at 2 months of 
age, in the absence of any known trauma. With respect to development, she sat 
up at 10 months, walked at 18 months, and spoke several words by 2 years of 
age. Neutropenia was evident since the first few months of life. Mild conductive 
hearing loss was diagnosed at 22 months of age. At 3 years of age, her growth 
parameters were: weight 7.7 kg (Z= -4.6), height 71 cm (Z= -6.2), and 
occipitofrontal head circumference 48.5 cm (Z= -0.2). Arm span was 6 percent 
less than height, and palm and hand were at the 50th percentile for 6 and 9 
months, respectively. She had a closed fontanelle, readily visible veins on her 
chest, full range of joint motion, and tibial bowing. Neurologic exam was 
unremarkable. Radiographs revealed relatively enlarged skull with Wormian 
bones, generalized shortening of all long bones and tubular bones in the hand, 
bowing of the forearms, mild epiphyseal and metaphyseal irregularity in all 
extremities, and mild metaphyseal cupping in the tubular bones of the 
hands. There were mild vertebral endplate irregularities at multiple levels as well 
as mild platyspondyly, and distal sacrococcygeal dysgenesis.  
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At 29 months, she developed periorbital cellulitis and lymphadenopathy, and 
given neutropenia, she received 3 days of G-CSF at 5 mcg/kg/day. Her initial 
ANC was 1,080/uL, improved to 1,950/uL after 3 doses, which was deemed to be 
a better response than that seen in many genetically determined neutropenias, 
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Table S1: Ophthalmologic findings in individuals with Saul-Wilson 
syndrome. 
BCVA: Best corrected visual acuity; C/D: Cup-to-disc ratio; CE: Cataract 
extraction; CFP: Color fundus photography; CSM: Central, steady, maintained; 
ERG: Electroretinography; FAF: Fundus autofluorescence; LX(T): left intermittent 
exotropia; ND: Not determined; OCT: Optical coherence tomography; OD: right 
eye; ONH: Optic nerve head; OS: left eye; RCD: Rod-cone dystrophy; TAC: 
Teller acuity cards. 
 
Table S2: Growth parameters as measured by standard deviation scores 
compared to the general population. 
Scores calculated using UK90 (left) and WHO (right) reference standards. 
Growth parameters were corrected for gestational age. BMI, body mass index; 
HC, head circumference; SD, standard deviation. 
 
Supplementary Figures: 
Figure S1. Phenotypic findings in Saul-Wilson syndrome. 
(A) P6.1 at 2 months of age, showing a progeroid appearance, prominent 
forehead and visible veins, sparse eyebrows, blue sclerae, and thin vermilion of 
the lower lip. (B) P4.1 at 5 months of age, showing a prominent forehead with 
Supplementary  (Appendix, online only material, etc.)
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visible veins, sparse eyebrows, blue sclerae, and thin vermilion of the upper and 
lower lips. (C) P8.1 at 6 months of age showing prominent forehead and veins, 
low-set ears, and retrognathia. (D) P10.1 at 7 months of age, showing a 
progeroid appearance, prominent forehead and veins, sparse eyebrows, low 
hanging columella, and thin vermilion of the upper and lower lips. (E) P3.1 at 14 
months of age, showing prominent scalp veins. (F) P5.2 at 2 years 5 months, 
showing relative macrocephaly with a prominent forehead, and thin vermilion of 
the upper lip. (G) P5.1 at 5 years 10 months, showing prominent forehead and 
sparse eyebrows. (H) P2.1 at 29 years of age, showing a tall forehead, low-set 
ears, convex nasal ridge, and retrognathia. (I) P2.1 at 29 years, showing 
telebrachydactyly of toes, and metatarsus varus despite numerous surgical 
repairs for clubfoot.  
 
Figure S2. Skeletal findings. 
Top row showing radiographs from P1.1 at age 6 months (C, E, I), 2 years (A) 
and 4 years 4 months (B, D, F, G, H). These images show age-dependent 
evolution of coxa valga (A-B), slender long bones with metaphyseal flaring and 
large epiphyses (C-D), hypoplasia of the proximal fibula (C-D), and brachydactyly 
(E-F). There is also platybasia (G) and craniovertebral junction stenosis (H). 
Platyspondyly is seen only at younger age (I). 
Bottom row (J-N) showing radiographs from P2.1 at age 29 years of age. In the 
adult, note degenerative joint disease of large joints (J, L), overtubulation of the 
	 3	
long bones (K), Madelung-like deformity of the forearm and wrist (L-M), and tall 
vertebral bodies with vertebral hypoplasia at the thoracolumbar junction (N). 
 
Figure S3. Long bone fractures in individuals with Saul-Wilson syndrome. 
(A) P13.1 at 2 months of age showing a right humeral fracture; note in addition 
casting of bilateral lower extremities for treatment of clubfoot. (B) P5.2 at 2 years 
9 months showing a left femoral fracture. (C) P10.1 at 5 years 7 months showing 
a left femoral fracture. (D) P12.1 at 30 years 2 months showing intramedullary 
rod as treatment for a prior left femoral fracture.  
 
Figure S4. Nonunion of right femur. 
(A) P7.1 at 16 years 6 months around the time of hip revision for nonunion of the 
right femoral osteotomy. (B) Persistence of nonunion 11 years later at 27 years 7 
months. Note also degenerative joint disease of the right hip with marked joint 
space narrowing. 
 
Figure S5. Laboratory findings in Saul-Wilson syndrome. 
ALT, alanine aminotransferase; ANC, absolute neutrophil count; AST, aspartate 
aminotransferase. Red lines indicate upper limit of normal (ALT and AST) and 
lower limit of normal (ANC).  
 
	
 Pt 1.1 Pt 2.1 Pt 7.1 Pt 10.1 
Age (yrs) 4 29 27 11 
BCVA CSM (TAC: 20/50) 20/32 OD, 20/40 OS 20/40 OD, 20/50 OS 20/40 OD, 20/100 OS 
Axial Length 
(mm) 
20.47 / 20.13 22.51 / 23.37 23.35 / 23.35 20.30 / 20.53 
Alignment Orthophoria Orthophoria Orthophoria LX(T) 





Lamellar cataract Pseudophakia (CE at 2 
and 4 yo); lamellar 
cataract preop 
Pseudophakia (CE at 20 
yo) 
Pseudophakia 
Retina Preserved macula; 
attenuated vessels; 
mottling with peripheral 
atrophy and 
depigmentation 




bony spicules especially 
nasal and superior (with 
some inferiorly) 
Posterior staphyloma; 
moderate to severe 
vascular attenuation; 
midperipheral spicules 
and retinal atrophy; 
chorioretinal lesions 
Preserved central island, 
with extensive bony 




Optic Nerve C/D 0.0; elevated ONH 
likely drusen 
C/D 0.1; trace pallor; 
temporal crescent 











Color Vision ND D15 fail OS, scotopic 
axis 
Pass D15 and Ishihara Ishihara 15/16 OD and 
13/16 OS 
Visual Field ND Constricted I4e and I1e Constricted V4e and I4e ND 
OCT Bioptigen Cirrus Cirrus Cirrus 
ERG ND RCD Photopic only ND 
Fundus 
Imaging 
RetCAM CFP, FAF CFP, FAF CFP, FAF 





0 0,25 0,5 0,75 1 1,5 2 3 4 5 6 7 8 0 0,25 0,5 0,75 1 1,5 2 3 4 5 6 7 8
P1.1 -2,37 -4,93 -4,03 -4,90 -5,48 -5,66 -5,92 -5,19 -5,50 P1.1 -1,89 -5,39 -4,31 -5,25 -5,87 -6,06 -6,09 -5,28 -5,59
P2.1 -1,03 -3,16 -3,47 -3,76 -3,84 -4,42 -4,74 -5,05 -4,93 -5,31 -5,55 -5,80 -6,15 P2.1 -0,46 -3,09 -3,23 -3,54 -3,66 -4,31 -4,53 -4,92 -4,88 -5,11 -5,22 -5,40 -5,67
P3.1 -3,07 -5,76 -5,49 -6,34 -6,88 -7,06 -7,06 -6,92 -6,86 -6,89 -6,66 -6,79 -7,07 P3.1 -2,63 -6,28 -5,85 -6,76 -7,34 -7,51 -7,24 -6,98 -6,92 -6,81 -6,57 -6,59 -6,76
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